Maxygen Quote Page (MAXY)

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Maxygen To Receive $30M Payment From Bayer

5/15/2012 by Pharmaceutical Online

Maxygen to Receive $30 Million Payment from Bayer

5/14/2012 by PharmiWeb.com - UK

Maxygen gets $30M payment from Bayer

5/14/2012 by Silicon Valley / San Jose Business Journal - San Jose CA

Maxygen (MAXY) Will Receive $30M Payment from Bayer

5/14/2012 by StreetInsider.com

Maxygen to receive $30M payment from Bayer

5/14/2012 by Theflyonthewall.com

Maxygen to Receive $30 Million Payment from Bayer

5/14/2012 by Business Wire

Maxygen Reports First Quarter 2012 Financial Results

5/8/2012 by PharmiWeb.com - UK

Maxygen: Bayer $30 Million Payment Likely In 2012

5/2/2012 by Seeking Alpha

Maxygen Reports Fourth Quarter and Year End 2011 Financial Results

3/8/2012 by Business Wire

Maxygen: A Biotech Play With Low Downside - Part 1

3/1/2012 by Seeking Alpha

Maxygen Announces $10 Million Stock Repurchase Program

1/10/2012 by Genetic Engineering News

Maxygen announces $10M stock rpurchase program

1/10/2012 by Theflyonthewall.com

Maxygen Announces $10 Million Stock Repurchase Program

1/10/2012 by Business Wire

Maxygen 'surprised' by US BARDA radiation treatment contract rejection

11/11/2011 by Script World Pharmaceutical News - UK

BARDA Rejects Maxygenâs Proposal to Develop MAXY-G34 for Acute Radiation Syndrome

11/10/2011 by Genetic Engineering News

Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome

11/10/2011 by PharmiWeb.com - UK

Maxygen not to awarded contract for development of Maxy-G34 by BARDA

11/9/2011 by Theflyonthewall.com

Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome

11/9/2011 by Business Wire

Maxygen Reports Third Quarter 2011 Financial Results

11/8/2011 by PharmiWeb.com - UK

Maxygen Reports Third Quarter 2011 Financial Results

11/7/2011 by Business Wire

Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding

10/11/2011 by PharmiWeb.com - UK

Maxygen (MAXY) Shares Rise Amid Final Rejection of All Claims of Amgen '804 Patent

10/11/2011 by StreetInsider.com

Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding

10/10/2011 by Business Wire

Holy Share Buyback, Batman!

9/9/2011 by The Motley Fool

Maxygen's board approves $10M boost to repurchase plan

9/9/2011 by Script World Pharmaceutical News - UK

Maxygen's board approves $10M stock boost

9/8/2011 by Silicon Valley / San Jose Business Journal - San Jose CA

Maxygen Announces $10 Million Increase in Stock Repurchase Program

9/8/2011 by PharmiWeb.com - UK

Maxygen (MAXY) Boosts Buyback by $10M Common

9/8/2011 by StreetInsider.com

Maxygen announces $10M increase in stock repurchase program

9/8/2011 by Theflyonthewall.com

Maxygen Announces $10 Million Increase in Stock Repurchase Program

9/8/2011 by Business Wire

Maxygen Reports Second Quarter 2011 Financial Results

8/9/2011 by PharmiWeb.com - UK

Sale gain boosts Maxygen Q2 profit to $54.5M

8/8/2011 by Silicon Valley / San Jose Business Journal - San Jose CA

Maxygen (MAXY) Reports Q2 Earnings of $1.86

8/8/2011 by StreetInsider.com

Hatteras’ Ken Lee joins BioCryst board

6/27/2011 by Triangle Business Journal - Raleigh NC

Maxygen Announces $10 Million Stock Repurchase Program

5/31/2011 by Genetic Engineering News

Maxygen plans $10M stock repurchase

5/31/2011 by Silicon Valley / San Jose Business Journal - San Jose CA

Maxygen (MAXY) Board Authorizes $10M Buyback Program

5/31/2011 by StreetInsider.com

Maxygen Announces $10 Million Stock Repurchase Program

5/31/2011 by Benzinga

Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas

5/17/2011 by PharmiWeb.com - UK

Hedge Fund Centaur Capital Buys CSTR, WDC, DELL, AHL, DO, CSCO, Sells NOC, VOD, BH, LH, EMC

5/6/2011 by GuruFocus

Ticker

Maxygen